MENU
CCCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
C4 Therapeutics (CCCC) Earnings Date & Reports
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives... Show more
A.I. Advisor
published Earnings
CCCC is expected to report earnings to rise 11.11% to -20 cents per share on November 05
Q3'26
Est.
$-0.20
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.11
Q3'25
Missed
by $0.03
The last earnings report on August 11 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 971.30K shares outstanding, the current market capitalization sits at 391.22M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
104
Web
https://www.c4therapeutics.com